Research and Markets: Monoclonal Antibodies Market to 2017 – Monoclonal …Benzinga (press release)The first FDA-approved therapeutic monoclonal antibody was a murine IgG2a CD3 specific transplant rejection drug, OKT3 (also called muromonab) in 1986. T…
InPharmBig pharma: big rewards come from big risksInPharmThis effort produced tofacitinib, a very exciting, first-in-class small molecule to treat rheumatoid arthritis, psoriasis and may prove to be valuable in preventing organ transplant rejection. I …
University of Rochester NewsroomSyracuse Woman Raises Awareness of Joining Organ Donor RegistryUniversity of Rochester NewsroomKankoski's diagnosis has made her very aware of the dire community need for greater participation in organ donation. In N…
USA TodayFederal policy blocks many gay men from blood donationUSA TodayBut three blood-related organizations — the Red Cross, America's Blood Centers and the transfusion and cellular therapy organization AABB — say modern HIV detection methods m…
Regeneration of specialized cells offers hope for treating chronic kidney diseaseEurekAlert (press release)Damage to podocytes — a specialized type of epithelial cell in the kidney — occurs in more than 90 percent of all chronic kidney disease. Now r…
ThirdAgeBlues legend Hubert Sumlin dies at 80Sacramento BeeHubert Sumlin, who died of heart failure Sunday at 80, is a crucial figure whose remarkable, mercurial, breathtaking style and long-standing legacy (Jimi Hendrix and Stevie Ray Vaughan owed him…
Blood donation raises money for Toys for TotsWWMT(NEWSCHANNEL 3) – You've got a chance over the next few days to help make it a merry Christmas for a child in need and also save a life at the same time. For every person who donates blood at one of …
Universitas HelsingiensisA transplant is not just a spare partUniversitas HelsingiensisHeart transplant surgery is a risky procedure, and not only in the sense of mere survival. According to Professor Shildrick, what is at stake is nothing less than ou…
Ricerca per Alzheimer, schizofrenia e sclerosi multiplaANSA.itNel dettaglio, si tratta di "Daclizumab", molecola sviluppata in partnership con Biogen, in fase tre di sviluppo per il trattamento della sclerosi multipla recidivante-remittente, …
Novartis to report cancer drug data at SABCS and ASH 2011ZenopaSABCS highlights will include phase III data on everolimus for advanced breast cancer, as well as further findings on Zometa and BKM120. Meanwhile, the ASH presentations will focus on appro…